Late-onset schizophrenia is relatively rare. Further history may reveal prodromal symptoms that mimic ... as well as bipolar disorder, manic phase.

Millions of people across the United States live with schizophrenia, and in Northwest Arkansas, UAMS aims to join in aiding ...

AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative ...

Researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion of the brain that controls approach vs. avoidance behavior.

Genes aren’t destiny. The ARCH × Φ model explains how brain wiring, motivation, culture, and timing interact—multiplying risk ...

Mount Sinai researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion ...

After decades of stagnation in the drug treatment of schizophrenia, a handful of new therapies have raised hopes of improvement – but one of them has just failed a pair of phase 3 trials.

In July the phase 3 SERENITY I and SERENITY 2 trials met their primary endpoints in schizophrenia and bipolar disorder, respectively. The company noted the drug produced highly statistically ...

There is a difference between the terms "tardive dyskinesia" and "tardive syndrome" that clinicians should be aware of when providing care.

Koplik spots (gray–white papules on the buccal mucosa) may be seen during this prodromal phase. Approximately 3–4 days after the prodromal symptoms, the typical exanthem of coalescing ...